BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24585758)

  • 21. The genetics of hemoglobin A2 regulation in sickle cell anemia.
    Griffin PJ; Sebastiani P; Edward H; Baldwin CT; Gladwin MT; Gordeuk VR; Chui DH; Steinberg MH
    Am J Hematol; 2014 Nov; 89(11):1019-23. PubMed ID: 25042611
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Gardner K; Fulford T; Silver N; Rooks H; Angelis N; Allman M; Nkya S; Makani J; Howard J; Kesse-Adu R; Rees DC; Stuart-Smith S; Yeghen T; Awogbade M; Sangeda RZ; Mgaya J; Patel H; Newhouse S; Menzel S; Thein SL
    Blood Adv; 2018 Feb; 2(3):235-239. PubMed ID: 29437638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
    Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
    Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.
    Sebastiani P; Farrell JJ; Alsultan A; Wang S; Edward HL; Shappell H; Bae H; Milton JN; Baldwin CT; Al-Rubaish AM; Naserullah Z; Al-Muhanna F; Alsuliman A; Patra PK; Farrer LA; Ngo D; Vathipadiekal V; Chui DH; Al-Ali AK; Steinberg MH
    Blood Cells Mol Dis; 2015 Mar; 54(3):224-30. PubMed ID: 25703683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
    Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
    Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variants associated with fetal hemoglobin levels show the diverse ethnic origin in Colombian patients with sickle cell anemia.
    Fong C; Menzel S; Lizarralde MA; Barreto G
    Biomedica; 2015; 35(3):437-43. PubMed ID: 26849705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.
    Galarneau G; Palmer CD; Sankaran VG; Orkin SH; Hirschhorn JN; Lettre G
    Nat Genet; 2010 Dec; 42(12):1049-51. PubMed ID: 21057501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
    Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
    Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania.
    Nkya S; Mwita L; Mgaya J; Kumburu H; van Zwetselaar M; Menzel S; Mazandu GK; Sangeda R; Chimusa E; Makani J
    BMC Med Genet; 2020 Jun; 21(1):125. PubMed ID: 32503527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variant in the BCL11A (rs1427407), but not HBS1-MYB (rs6934903) loci associate with fetal hemoglobin levels in Indian sickle cell disease patients.
    Bhanushali AA; Patra PK; Nair D; Verma H; Das BR
    Blood Cells Mol Dis; 2015 Jan; 54(1):4-8. PubMed ID: 25457385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
    Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
    Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
    Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia.
    Wyszynski DF; Baldwin CT; Cleves MA; Amirault Y; Nolan VG; Farrell JJ; Bisbee A; Kutlar A; Farrer LA; Steinberg MH
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):23-33. PubMed ID: 15040424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
    Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
    Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
    Menzel S; Thein SL
    Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia.
    Adeyemo TA; Ojewunmi OO; Oyetunji IA; Rooks H; Rees DC; Akinsulie AO; Akanmu AS; Thein SL; Menzel S
    PLoS One; 2018; 13(6):e0197927. PubMed ID: 29879141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Existence of HbF Enhancer Haplotypes at
    Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
    Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
    [No Abstract]   [Full Text] [Related]  

  • 39. The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.
    Adekile A
    Med Princ Pract; 2021; 30(3):201-211. PubMed ID: 32892201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Modifiers of Sickle Cell Anemia Phenotype in a Cohort of Angolan Children.
    Ginete C; Delgadinho M; Santos B; Miranda A; Silva C; Guerreiro P; Chimusa ER; Brito M
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.